Key result
Prednisone therapy induces rapid ~1.5-cm benign mediastinal lipomatosis within 3 weeks of treatment.
Why the study?
Symptomatic polyserositis is an extremely unusual presentation of sarcoidosis, and benign mediastinal lipomatosis is an uncommon complication of steroid therapy that can masquerade as a cardiac mass.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Clinicians should recognize steroid-induced lipomatosis as a tumor mimic in sarcoidosis; extends known associations but leaves open optimal management strategies.
•Sarcoidosis can present with persistent and recurrent polyserositis.•Steroid therapy is associated with benign ML.•Advanced imaging can help characterize concerning lesions seen on echocardiography.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2020) conducted a case report in Sarcoidosis-induced polyserositis and steroid-induced mediastinal lipomatosis (n=1). Prednisone, ibuprofen, and colchicine was evaluated on Clinical resolution and diagnosis of extrapericardial mass. Prednisone therapy for sarcoidosis-induced polyserositis induced a 1.5 cm benign mediastinal lipomatosis mass within 3 weeks, which was confirmed via cardiac MRI and managed conservatively.
Synapse has enriched 10 related papers. Consider them for comparative context: